SeaStar Medical (NASDAQ:ICU – Get Free Report) and Straumann (OTCMKTS:SAUHY – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.
Insider & Institutional Ownership
1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for SeaStar Medical and Straumann, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 1 | 0 | 2.00 |
| Straumann | 2 | 3 | 2 | 0 | 2.00 |
Valuation & Earnings
This table compares SeaStar Medical and Straumann”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $1.71 million | 8.62 | -$12.15 million | ($3.91) | -0.86 |
| Straumann | $3.14 billion | 5.86 | $429.59 million | N/A | N/A |
Straumann has higher revenue and earnings than SeaStar Medical.
Profitability
This table compares SeaStar Medical and Straumann’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -795.51% | -162.75% | -109.89% |
| Straumann | N/A | N/A | N/A |
Risk & Volatility
SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the S&P 500. Comparatively, Straumann has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.
Summary
Straumann beats SeaStar Medical on 7 of the 11 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Straumann
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
